Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Management of Chemical Toxicity in Pediatrics11. Momeni A, Aminjavaheri M. Skin manifestations of mustard gas in a group of 14 children and teenagers: a clinicalstudy. Inter J Dermatol. 1994:33(3):184–187.12. Foroutan SA. Medical notes concerning chemical warfare, Part I. Kowsar Med J. 1996; 1(1):1–8.13. Foroutan SA. Medical notes concerning chemical warfare, Part II. Kowsar Med J. 1996; (2):1–23.14. Foroutan SA. Medical notes concerning chemical warfare, Part III. Kowsar Med J. 1997;2(1):1–15.15. Foroutan SA. Medical notes concerning chemical warfare, Part IV. Kowsar Med J. 1997;2(2):1–15.16. Foroutan SA. Medical notes concerning chemical warfare, Part V. Kowsar Med J. 1997;2(3):1–9.17. Foroutan SA. Medical notes concerning chemical warfare, Part VI. Kowsar Med J. 1998;2(4):1–18.18. Foroutan SA. Medical notes concerning chemical warfare, Part VII. Kowsar Med J. 1998;3(1):1–10.19. Foroutan SA. Medical notes concerning chemical warfare, Part IX. Kowsar Med J. 1996;3(3):1–16.20. Foroutan SA. Medical notes concerning chemical warfare, Part X. Kowsar Med J. 1999;3(4):1–12.21. Foroutan SA. Medical notes concerning chemical warfare, Part XI. Kowsar Med J. 1999;4(1):1–7.22. Vogel FJ. The Chemical Weapons Convention: Strategic Implications for the United States. Monograph. The Strategic StudiesInstitute at the US Army War College: Carlisle, Penn; 1997.23. Sidell FR. Chemical agent terrorism. Ann Emerg Med. 1996;28(2):223–224.24. Nagao M, Takatori T, Matsuda Y, Nakajima M, Iwase H, Iwadate K. Definitive evidence for the acute sarin poisoningdiagnosis in the Tokyo subway. Toxic Appl Pharm. 1997;144:198–203.25. Tsuchihashi H, Katagi M, Nishikawa M, Tatsuno M. Identification of metabolites of nerve agent VX in serum collectedfrom a victim. J Anal Toxicol. 1998;22(5):383–388.26. Matsuda Y, Nagao M, Takatori T, Niijima H, Nakajima M, Iwase H, et al. Detection of the sarin hydrolysis product informalin-fixed brain tissues of victims of the Tokyo subway terrorist attack. Toxicol Appl Pharm. 1998;150:310–320.27. Solberg Y, Nachtomi-Shick O, Shemer Y, Alcalay M. Terror in Japan: mass-intoxication with the nerve-agent sarin.Harefuah. 1998;135(7–8):268–271.28. Okudera H. Clinical features on nerve gas terrorism in Matsumoto. J Clin Neurosci. 2002;9(1):17–21.29. Yanagisawa N, Morita H, Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci.2006;249:76–85.30. Blaschke GS, Lynch J. Terrorism: its impact on primary pediatrics, Part I. Pediatr Ann. 2003;32(2):80–84.31. Blaschke GS, Palfrey JS, Lynch J. Advocating for children during uncertain times. Pediatr Ann. 2003;32(4):271–274.32. Committee on Environmental Health and Committee on Infectious Diseases. Chemical-biological terrorism and itsimpact on children: a subject review. Pediatrics. 2000;105:662–670.33. Rotenberg JS, Newmark J. Nerve agent attacks on children: diagnosis and management. Pediatrics. 2003;112:648–658.34. Brackett DW. Holy Terror Armageddon in Tokyo. New York, NY: Weatherhill, Inc; 1996.685